Showing results (1-10 of 402) with videos related to
Sort By:
Pageof 41
Frontiers in Oncology|August 29, 2022
Patient-derived cancer models: Valuable platforms for anticancer drug testingSofia Genta, Bryan Coburn, David W Cescon, et al.International Journal of Molecular Sciences|January 21, 2023
Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous CancersPavlina Spiliopoulou, Olga Vornicova, Sofia Genta, et al.International Journal of Molecular Sciences|May 13, 2026
Pan-Cancer Pre-Treatment ctDNA Detection Using a Highly Sensitive Tumor-Informed AssayScott Strum, Clodagh Murray, Sofia Genta, et al.Cancer Treatment Reviews|November 23, 2020
Bugs as drugs: The role of microbiome in cancer focusing on immunotherapeuticsDaniel V Araujo, Geoffrey A Watson, Marc Oliva, et al.Cancers|January 26, 2024
The Clinical, Genomic, and Transcriptomic Landscape of BRAF Mutant CancersSuzanne Kazandjian, Emmanuelle Rousselle, Matthew Dankner, et al.Msystems|July 13, 2021
Two-Target Quantitative PCR To Predict Library Composition for Shallow Shotgun SequencingMatthew Y Cho, Marc Oliva, Anna Spreafico, et al.International Journal of Molecular Sciences|November 13, 2025
Navigating Treatment Sequencing in Advanced HR+/HER2- Breast Cancer After CDK4/6 Inhibitors: Biomarker-Driven Strategies and Emerging TherapiesDana P Narvaez, David W CesconCurrent Opinion in Oncology|September 23, 2021
Accelerating drug access from advanced to early breast cancer: the special case of oral selective estrogen receptor degradersBrooke E Wilson, David W CesconGenome Biology|October 8, 2016
DNA replication stress: a source of APOBEC3B expression in breast cancerDavid W Cescon, Benjamin Haibe-KainsBreast (Edinburgh, Scotland)|December 14, 2021
Development of novel agents for the treatment of early estrogen receptor positive breast cancerMitchell J Elliott, David W CesconPageof 41